Latest News
December 1, 2009
Pique Therapeutics and Technomark Life Sciences Sign Co-Development and License Agreement for PT 107 (PR)
Oct 13, 2009
Kylin Sees Potential for pRNA with Aptamers, But Keeps Its Eye on RNA Interference (GenomeWeb)
Oct 8, 2009
Catena Selected to Present at Southeastern BIO Investor Forum (SEBIO)
Oct 6, 2009
Kylin Therapeutics Receives Notice of Allowance for Key Therapeutic RNA Patent Covering pRNAi (PR)
June 10, 2009
Cancer Firm "Piques" Investor Interest with Series A (BioWorld)
June 9, 2009
Pique Therapeutics Raises Series A Round of Financing (PR)
June 9, 2009
Piedmont Angel Network Invests in Pique Therapeutics (PR)
June 8, 2009
Pete Meldrum Inducted into Utah Technology Council Hall of Fame (PR)
June 1, 2009
Exigent Pharmaceuticals Among 2009 Tech 50, Most Promsing Technology Companies (TechJournalSouth)
April 13, 2009
Catena Pharmaceuticals Emerging Company Profile (BioCentury)
March 5, 2009
Catena Pharmaceuticals Selected to Present at CED's Venture 2009 Conference April 22-23 (NCCED)
March 4, 2009
Purdue University Venture Fund Invests in Kylin Therapeutics (Journal & Courier)
March 3, 2009
Catena Pharmaceuticals Selected to Present at BIO's National Venture Capital Conference March 31-April 1 (BIO)
February 2, 2009
Exigent Pharmaceuticals Wants to Beat Drug-Resistant Bugs (TechJournal South)
January 23, 2009
Catena Pharmaceuticals Selected to Present at WBT Showcase March 23-24, 2009 (WBT Showcase)
January 8, 2009
Kylin Lands $1.2MM Grant from State of Indiana (Journal & Courier)
[GPV News Archives]
[Portfolio Company News Archives]
